Morning Trend | CSPC PHARMA (1093.HK) Golden Cross Innovative Drug Theme Fermentation Strongly Leads the Rise
CSPC PHARMA (1093.HK) became a target for pharmaceutical funds early yesterday morning, performing strongly throughout the day and reaching a new high for the period. Positive news emerged that the company's innovative drugs are expected to be included in the medical insurance system, directly igniting enthusiasm for buying in the pharmaceutical sector. During the trading session, there was a coordinated increase in volume and price, with major funds gathering to drive the stock to lead the industry. After the announcement, overseas institutions quickly increased their allocation to Hong Kong pharmaceutical leaders, with CSPC PHARMA receiving significant attention from mainstream funds in the short term. The sector's rise benefited from support from medical insurance policies and a short-term recovery in industry prosperity. From a technical perspective, the MACD has formed a golden cross, with the 5-day moving average providing support, and the overall K-line showing a smooth upward trend. At one point during the session, it surged to a high, but the divergence between long and short funds gradually narrowed, closing firmly above the key support area. It is worth noting that the implementation of innovative drugs still has a cycle, and if the policy direction and industry sentiment reverse, major funds may take profits. The rotation of market mainline hotspots is intensifying, and if negative news reappears, there could be significant volatility to watch out for. The operational suggestion is to pay attention to major changes and announcements in the industry, maintain flexible positions, and avoid blindly chasing prices to guard against the expansion of short-term risks. The medium-term bullish trend is good, and further upward space is expected
Technical Forecast·
